More than a traditional CRO, Q2BI is a trusted strategic partner that empowers global life science companies with technology-driven insights and human expertise. We're redefining the deliverable-focused CRO model into a more dynamic, intelligent, and fully integrated partnership.
Guided by our vision to accelerate hope to patients, we exceed client expectations by providing distinctive data solutions that blend AI-powered systems, top-tier clinical research services, and attentive, personalized support, empowering clients to reach their milestones with confidence and ease.
To power the future of clinical research through people-centered, innovative, and trusted clinical data solutions, accelerating hope to patients.
We never compromise on excellence
We embrace technology to push boundaries
We move quickly and deliver on time, every time
We care about the people behind every project
Comprehensive oncology clinical development support from Phase I to NDA
Expert support for hematological malignancies and blood disorders
Expert CNS trial support for complex neurological endpoints
Autoimmune disease trials with complex endpoint expertise
Anti-infective and vaccine clinical development expertise
Cardiovascular outcome trials and cardiac safety expertise
Ocular disease trials with vision endpoint expertise
Orphan drug development with innovative trial designs
Comprehensive endocrine and metabolic disease clinical trial solutions
We integrate clinical intelligence with data-driven biometrics to accelerate your development timeline and improve data quality.
I. Origin
In 2009, Gary Huang founded Q2BI with a conviction: quality work for a quality world is more than a principle, it is a promise.
A promise to sponsors, sites, and most importantly, to patients waiting for treatments that may change or save their lives.
In clinical research, precision is not optional, and time is not abstract. A single oversight can alter a critical decision; a delay can mean a missed opportunity for treatment. From the beginning, we understood that quality must be foundational, and intelligence essential to delivering it without compromise.
Our guiding belief: uphold the highest standards while accelerating the path from data to decision, and from decision to care.
II. Evolution
Q2BI's trajectory has been defined by trust. Our reputation spread through referrals: sponsor to sponsor, team to team, each engagement reinforcing our reliability, rigor, and follow-through.
Today, we are more than 300 professionals worldwide, spanning data management, statistics, statistical programming, medical writing, and software engineering. We share a disciplined commitment to data integrity and reliable delivery.
What began as a data-focused service organization has evolved into a technology-enabled strategic partner. We work as an extension of our clients' teams, measuring success not by contracts completed, but by outcomes achieved.
III. Core
Innovation is in our DNA. When manual processes dominated the industry, we embedded "BI" (Business Intelligence) into our name: a vision that biometrics should be propelled by technological insight, not mere effort.
From the outset, we built automation scripts, rule-based checks, and platform tools to reduce repetition, surface issues earlier, and bring predictability to timelines. These investments laid the groundwork for scalable, sustainable quality.
As AI matured, we integrated it thoughtfully into our platforms, always guided by our uncompromising standards. We pursue technology not for novelty, but to help sponsors make clearer decisions with greater speed and confidence.
IV. Mission
Our work is technical, but our purpose is profoundly human.
Behind every table and dataset is a person, someone waiting, hoping, fighting. Someone who needs innovation not someday, but sooner.
Q2BI exists to accelerate the path from research to reality. To bring promising therapies to patients sooner, with confidence and care. To power progress with the intelligence and efficiency we've championed from our first day.
Our work is more than data. More than deadlines. It is about advancing hope, one study, one sponsor, one patient at a time.
Stay updated with our latest breakthroughs, industry insights, and innovations accelerating the future of clinical research.
Featured Article
From database build to final lock, our CDM experts ensure your data is accurate, complete, and compliant with regulatory standards.
View Details
Submit an RFP to learn more about how our innovative solutions can help your organization.
Submit RFPGuided by our vision to accelerate hope to patients, we exceed client expectations by providing distinctive data solutions that blend AI-powered systems, top-tier clinical research services, and attentive, personalized support, empowering clients to reach their milestones with confidence and ease.
To power the future of clinical research through people-centered, innovative, and trusted clinical data solutions, accelerating hope to patients.
We never compromise on excellence
We embrace technology to push boundaries
We move quickly and deliver on time, every time
We care about the people behind every project
Comprehensive oncology clinical development support from Phase I to NDA
Expert support for hematological malignancies and blood disorders
Expert CNS trial support for complex neurological endpoints
Autoimmune disease trials with complex endpoint expertise
Anti-infective and vaccine clinical development expertise
Cardiovascular outcome trials and cardiac safety expertise
Comprehensive endocrine and metabolic disease clinical trial solutions
Ocular disease trials with vision endpoint expertise
Orphan drug development with innovative trial designs
Where Quality Is a Promise and Intelligence Accelerates Hope
I. Origin
In 2009, Gary Huang founded Q2BI with a conviction: quality work for a quality world is more than a principle, it is a promise.
A promise to sponsors, sites, and most importantly, to patients waiting for treatments that may change or save their lives.
In clinical research, precision is not optional, and time is not abstract. A single oversight can alter a critical decision; a delay can mean a missed opportunity for treatment. From the beginning, we understood that quality must be foundational, and intelligence essential to delivering it without compromise.
Our guiding belief: uphold the highest standards while accelerating the path from data to decision, and from decision to care.
II. Evolution
Q2BI's trajectory has been defined by trust. Our reputation spread through referrals: sponsor to sponsor, team to team, each engagement reinforcing our reliability, rigor, and follow-through.
Today, we are more than 300 professionals worldwide, spanning data management, statistics, statistical programming, medical writing, and software engineering. We share a disciplined commitment to data integrity and reliable delivery.
What began as a data-focused service organization has evolved into a technology-enabled strategic partner. We work as an extension of our clients' teams, measuring success not by contracts completed, but by outcomes achieved.
III. Core
Innovation is in our DNA. When manual processes dominated the industry, we embedded "BI" (Business Intelligence) into our name: a vision that biometrics should be propelled by technological insight, not mere effort.
From the outset, we built automation scripts, rule-based checks, and platform tools to reduce repetition, surface issues earlier, and bring predictability to timelines. These investments laid the groundwork for scalable, sustainable quality.
As AI matured, we integrated it thoughtfully into our platforms, always guided by our uncompromising standards. We pursue technology not for novelty, but to help sponsors make clearer decisions with greater speed and confidence.
IV. Mission
Our work is technical, but our purpose is profoundly human.
Behind every table and dataset is a person, someone waiting, hoping, fighting. Someone who needs innovation not someday, but sooner.
Q2BI exists to accelerate the path from research to reality. To bring promising therapies to patients sooner, with confidence and care. To power progress with the intelligence and efficiency we've championed from our first day.
Our work is more than data. More than deadlines. It is about advancing hope, one study, one sponsor, one patient at a time.
Stay updated with our latest breakthroughs, industry insights, and innovations accelerating the future of clinical research.
Featured Article
From database build to final lock, our CDM experts ensure your data is accurate, complete, and compliant with regulatory standards.
View DetailsAccelerating Drug Development with Data-Driven Biometrics & Clinical Intelligence.
Submit RFP
